UNSPSC 51332842: Chlorpromazine pamoate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C23H16O6.C17H19CLN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85RG9X8ZHE. The term chlorpromazine pamoate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule chlorpromazine pamoate under HS 29343090. As of Q4 2014, CHLORPROMAZINE PAMOATE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCCN1C2CCCCC2SC3C1CC(CC3)CL.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51332842 Chlorpromazine pamoate is a Commodity code that nominally describes a specific antipsychotic medication, but recent state and local procurement activity tagged under this code shows a mismatch with its abstract scope. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS — solicits naloxone (an opioid-reversal agent) and safe drug deactivation systems for community health initiatives, not chlorpromazine pamoate. The procurement reflects demand for emergency medical supplies and controlled-substance management infrastructure rather than the antipsychotic pharmaceutical the code nominally names. State and local issuing bodies using this code to source pharmaceutical or health-related products appear limited in recent activity; Seminole County represents the only identified recent buyer under this specific Commodity designation.

Seminole County, Florida is the sole jurisdiction showing recent procurement activity under this code. The county posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida. The contract was structured as a competitive bid with quarterly deliveries, a two-year initial term with a one-year renewal option, and fixed-fee pricing. Vendors were required to submit bids electronically, maintain specified insurance coverage, provide drug-free workplace certification, and comply with E-Verify requirements. The procurement may have been funded through FEMA, introducing additional federal compliance obligations. The code shows minimal recent state and local activity overall, and the single identified opportunity does not substantively reflect the pharmaceutical scope the Commodity designation describes.